Yacobi A, Levy G
J Pharm Sci. 1977 Sep;66(9):1285-8. doi: 10.1002/jps.2600660920.
The serum protein binding of phenytoin, salicylic acid, sulfisoxazole, and warfarin was determined in normal human adults, in patients with impaired renal function (kidney donor and recipient), and in adult male Sprague--Dawley rats. The free fraction values for salicylate and sulfisoxazole were significantly correlated in all three groups. The other correlations were statistically significant in only one or two of these groups. There was a statistically significant negative correlation between albumin concentration and the free fraction values of salicylic acid and sulfisoxazole (but not of phenytoin and only under special circumstances with warfarin) in normal subjects and of phenytoin, salicylic acid, and sulfisoxazole (but not warfarin) in rats. No such correlation was observed for any of the drugs in patients with impaired renal function. These observations show that no single weakly acidic drug can serve as an index for quantitatively determining the effect of disease or species differences on the serum protein binding of other weakly acidic drugs.
在正常成年人、肾功能受损患者(肾脏供体和受体)以及成年雄性斯普拉格 - 道利大鼠中,测定了苯妥英、水杨酸、磺胺异恶唑和华法林的血清蛋白结合率。在所有三组中,水杨酸盐和磺胺异恶唑的游离分数值显著相关。其他相关性仅在其中一两组中具有统计学意义。在正常受试者中,白蛋白浓度与水杨酸和磺胺异恶唑(但不包括苯妥英,仅在特殊情况下与华法林)的游离分数值之间存在统计学显著负相关;在大鼠中,白蛋白浓度与苯妥英、水杨酸和磺胺异恶唑(但不包括华法林)的游离分数值之间存在统计学显著负相关。在肾功能受损患者中,未观察到任何一种药物存在这种相关性。这些观察结果表明,没有单一的弱酸性药物可以作为定量确定疾病或物种差异对其他弱酸性药物血清蛋白结合影响的指标。